Risperidone versus zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity: a long-term randomized, controlled, crossover study

@inproceedings{Rubio2006RisperidoneVZ,
  title={Risperidone versus zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity: a long-term randomized, controlled, crossover study},
  author={Gabriel Rubio and Isobel Martinez and Ana Recio and Guillermo Ponce and Francisco L{\'o}pez-Mu{\~n}oz and Cecilio {\'A}lamo and Miguel {\'A}ngel Jim{\'e}nez-Arriero and Tom{\'a}s Palomo},
  year={2006}
}
Background: Substance use disorders (SUDs) are present in more than 50% of subjects diagnosed with schizophrenia. However, there are no controlled studies assessing the efficacy of antipsychotic drugs in this subgroup of patients. The aim of the present work was to compare the efficacy of risperidone and zuclopenthixol in a sample of schizophrenic subjects with dual diagnosis. Method: Thirty-three male were selected for treatment with risperidone, while another 33 were treated with… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 48 REFERENCES

Tratamiento farmacológico de la esquizofrenia en pacientes con abuso/dependencia de drogas

  • G Rubio, MA Jiménez- Arriero, J Manzanares, G Ponce, T. Palomo
  • T eds. Guía para el tratamiento de los pacientes…
  • 2002

Revisión del tratamiento de la esquizofrenia en individuos con abuso de drogas

  • G Rubio, M. Casas
  • Actas Esp Psiquiatr
  • 2001

Risperidona en el tratamiento de pacientes psicóticos con abuso y dependencia de opiáceos

  • M Casas, M Gutierrez, J Gibert, J Bobes, C Roncero, I. Octavio
  • Actas Esp Psiquiatr
  • 2001

Similar Papers

Loading similar papers…